PHARMAGEST INTERACTIVE announces its participation in the 14th edition of the « Large and Midcap Event » in Paris
Pharmagest shares are eligible for the Equity Savings Plan
The PHARMAGEST Group will be meeting investors at the 14th edition of the Paris Large and Midcap Event on 2 and 3 October, 2014 at the Palais Brongniart.
The PHARMAGEST Group is the French leader in computer systems for pharmacies, with a 43.5 % share of the market, 9,800 clients and more than 750 employees. Since September 2007, the PHARMAGEST Group has also been present in Northern Europe with a 12 % market share in Belgium and Luxembourg through its subsidiary SABCO.
As a privileged partner to pharmacists for almost 30 years now, the PHARMAGEST Group designs innovative computer solutions for pharmacies and is developing a high potential E-Business E-Media activity intended for pharmaceutical laboratories.
The PHARMAGEST Group is also developing previously unpublished software solutions for Retirement Homes, (Care Homes and day centers for the elderly), through its subsidiary MALTA INFORMATIQUE.
The first Logiciel de Gestion à Portail Intégré (Integrated Portal Management Software - LGPI Global Services®), creator of value for the patient, pharmacist and laboratory, dynamizes sales, optimizes purchases and enriches advice to the patient. It is also the first permanent impact medium for pharmacies, supplying laboratories with direct communication towards the pharmacist and his patients.
At the heart of the digital revolution that is gradually establishing itself in the daily life of health professionals and patients alike, at the beginning of 2012, the PHARMAGEST Group created an e-Health business, bringing together the subsidiaries DIATELIC (expert systems), DOMEDIC EUROPE (intelligent pill dispenser DO-Pill SecuRTM) and KAPELSE (electronic health devices), structurally reinforced by the obtaining of several approvals for hosting health data.
Lesen Sie auch
Financial calendar:
- Publication of Q3 Turnover on 13 November 2014.
Find out the latest news from the group at www.pharmagest.com
Listed on the NYSE Euronext Paris(TM) - Compartment B
Indices CAC ® SMALL90 and CAC ® All-Tradable by inclusion
ISIN: FR 0000077687 - Reuters: PHA.PA - Bloomberg: - PMGI FP
Pharmagest shares are eligible for the Equity Savings Plan
Chairman of the Board of Directors:
Thierry CHAPUSOT
Managing Director:
Dominique PAUTRAT
Tel. 03 83 15 90 67 - dominique.pautrat@pharmagest.com
Analysts and Investor Relations:
Administrative and Financial Director: Jean-Yves SAMSON
Tel. 03 83 15 90 67 - jean-yves.samson@pharmagest.com
Press Relations:
FIN'EXTENSO - Isabelle APRILE
Tel. 01 39 97 61 22 - i.aprile@finextenso.fr
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: PHARMAGEST INTERACTIVE via Globenewswire